Cargando…

Cell State Transitions and Phenotypic Heterogeneity in Luminal Breast Cancer Implicating MicroRNAs as Potential Regulators

Luminal breast cancer subtypes respond poorly to endocrine and trastuzumab treatments due to cellular heterogeneity arising from the phenotype transitions, accounted for mainly by the loss of receptor expression. The origins of basal-like and human epidermal growth factor receptor 2 (HER2)-overexpre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richard, Vinitha, Nair, Madhumathy G., Jaikumar, Vishnu S., Jones, Sara, Prabhu, Jyothi S., Kerin, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967449/ https://www.ncbi.nlm.nih.gov/pubmed/36834918 http://dx.doi.org/10.3390/ijms24043497

Ejemplares similares

Biological Implications of MicroRNAs as Regulators and Biomarkers of Therapeutic Toxicities in Breast Cancer
por: Abbas Syed, Raza, et al.
Publicado: (2023)

MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype
por: Tariq, Muhammad, et al.
Publicado: (2023)

MicroRNAs in Molecular Classification and Pathogenesis of Breast Tumors
por: Richard, Vinitha, et al.
Publicado: (2021)

microRNAs suppress cellular phenotypic heterogeneity
por: Giri, Ritika, et al.
Publicado: (2014)

High expression of ACE2 in HER2 subtype of breast cancer is a marker of poor prognosis
por: Nair, Madhumathy G, et al.
Publicado: (2021)

Predictive and Prognostic Value of Selected MicroRNAs in Luminal Breast Cancer
por: Amorim, Maria, et al.
Publicado: (2019)

Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer
por: McAnena, Peter, et al.
Publicado: (2019)

MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications
por: Stahlhut, Carlos, et al.
Publicado: (2013)

Circulating microRNAs: promising breast cancer Biomarkers
por: Heneghan, Helen M, et al.
Publicado: (2011)

MicroRNAs: Fine Tuners of Monocyte Heterogeneity
por: Duroux-Richard, Isabelle, et al.
Publicado: (2019)

MicroRNAs as Novel Biomarkers for Breast Cancer
por: Heneghan, H. M., et al.
Publicado: (2010)

Data on alteration of hormone and growth factor receptor profiles over progressive passages of breast cancer cell lines representing different clinical subtypes
por: Nair, Madhumathy G., et al.
Publicado: (2016)

Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer
por: Zhang, Zhuo, et al.
Publicado: (2021)

Implications of MicroRNAs in Oncolytic Virotherapy
por: Bofill-De Ros, Xavier, et al.
Publicado: (2017)

Side Population Cells as Prototype of Chemoresistant, Tumor-Initiating Cells
por: Richard, Vinitha, et al.
Publicado: (2013)

Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs
por: Namløs, Heidi M., et al.
Publicado: (2012)

MicroRNAs in Muscle: Characterizing the Powerlifter Phenotype
por: D'Souza, Randall F., et al.
Publicado: (2017)

Multi-modal transcriptomic analysis unravels enrichment of hybrid epithelial/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer
por: Sahoo, Sarthak, et al.
Publicado: (2023)

Clinical implications of microRNAs in human glioblastoma
por: Mizoguchi, Masahiro, et al.
Publicado: (2013)

MicroRNAs Implicated in the Immunopathogenesis of Lupus Nephritis
por: Chafin, Cristen B., et al.
Publicado: (2013)

MicroRNAs and clinical implications in hepatocellular carcinoma
por: Mohamed, Amal Ahmed, et al.
Publicado: (2017)

Intratumour heterogeneity in microRNAs expression regulates glioblastoma metabolism
por: Alfardus, Huda, et al.
Publicado: (2021)

MicroRNAs and epithelial-mesenchymal transition in prostate cancer
por: Sekhon, Kirandeep, et al.
Publicado: (2016)

Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer
por: Legras, Antoine, et al.
Publicado: (2017)

Deciphering the Role of MicroRNAs in Neuroblastoma
por: Veeraraghavan, Vishnu Priya, et al.
Publicado: (2021)

Phenotypic heterogeneity drives differential disease outcome in a mouse model of triple negative breast cancer
por: Thankamony, Archana P., et al.
Publicado: (2023)

Differential expression of microRNAs as predictors of glioblastoma phenotypes
por: Bradley, Barrie S, et al.
Publicado: (2014)

MicroRNAs enrichment in GWAS of complex human phenotypes
por: Goulart, Luiz F, et al.
Publicado: (2015)

MicroRNAs distribution in different phenotypes of Aortic Stenosis
por: Fabiani, Iacopo, et al.
Publicado: (2018)

Brain Expressed microRNAs Implicated in Schizophrenia Etiology
por: Hansen, Thomas, et al.
Publicado: (2007)

MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality
por: Rota, Rossella, et al.
Publicado: (2011)

Therapeutic implications of microRNAs in pulmonary arterial hypertension
por: Lee, Aram, et al.
Publicado: (2014)

Advances in microRNAs: implications for immunity and inflammatory diseases
por: Sonkoly, E, et al.
Publicado: (2009)

Translational applications of microRNAs in cancer, and therapeutic implications
por: Kwok, Grace T., et al.
Publicado: (2017)

Role of microRNAs in COVID-19 with implications for therapeutics
por: Arghiani, Nahid, et al.
Publicado: (2021)

MicroRNAs Regulate Function in Atherosclerosis and Clinical Implications
por: Li, Zhaoyi, et al.
Publicado: (2023)

MicroRNAs in cancer metastasis: biological and therapeutic implications
por: Sell, Marie C., et al.
Publicado: (2023)

Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer
por: Patten, Darren K., et al.
Publicado: (2018)

Functional Regulation of Macrophage Phenotypes by MicroRNAs in Inflammatory Arthritis
por: Niu, Xiaoling, et al.
Publicado: (2019)

Detection of microRNAs in color space
por: Marco, Antonio, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_577553do9okkeh8k8u7tbhpvd2